FDA Inspection 1109080 — Phibro Suzhou Manufacturing Co., Ltd.
The FDA completed an inspection of Phibro Suzhou Manufacturing Co., Ltd. on October 25, 2019 in Suzhou. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Veterinary.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- October 25, 2019
- Fiscal Year
- 2020
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Suzhou (China)